首页
HTRF CD47/SIRP A BIND. KIT - 10K PTS


品牌: Revvity









产品介绍
产品信息
Overview
Signal-regulatory protein alpha (SIRP-alpha), also known as CD172a, is a cell surface protein expressed mainly by myeloid cells, such as macrophages. Its receptor, CD47, is ubiquitously expressed on the surface of all cells and has been found to be overexpressed in some cancers. CD47 binding to SIRP-alpha delivers a "Do Not Eat Me" signal to macrophages. In the case of a tumor, this signaling aids in tumor evasion of the immune system. Inhibitors of this interaction hold great promise for cancer immunotherapy.
Specifications
Assay Points | 10000 |
---|---|
Assay Target Type | Kit |
Assay Technology | HTRF |
Brand | HTRF |
Quantity | 1 |
Therapeutic Area | Oncology & Inflammation |
Unit Size | 10,000 Assay Points |
Video gallery


How it works
Assay principle
The CD47/SIRP binding assay includes human recombinant immune checkpoint partners tagged for detection (CD47 and SIRP alpha) and labelled anti-tag reagents for HTRF detection. Without an inhibitor, CD47 binds to SIRP alpha, and the binding of each detection reagent to its tagged target generates an HTRF signal. In the presence of compound, standard or an antibody blocking the CD47/SIRP alpha interaction, the HTRF signal decreases.
Assay protocol
This CD47/SIRP alpha binding assay can be run in a 96- or 384-well low volume white plate (20 µL final). As described here, samples or standards are dispensed directly into the assay plate, and the tagged CD47 & SIRP alpha protein are then added, followed by the dispensing of the HTRF reagents. The reagents labelled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.
Assay validation
Inhibitory effect of the blocking standard
Performing an 8-point dose response curve using the blocking standard provided in the kit. The CD47-SIRP alpha interaction is inhibited, with an IC50 of 2.6 nM.
Inhibitory effect of blocking antibodies
The inhibitory effects of three antibodies known to inhibit the CD47-SIRP alpha interaction were tested. The two anti-CD47 antibodies (B6H12 & B6H12.2) were shown to inhibit the interaction, with IC50s of 2.2 & 1.6 nM respectively. The anti-SIRP alpha antibody (SE5A5) disrupted the interaction, with an IC50 of 2.4 nM.
声明 :本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。